Top role for lo­cal sci­en­tist

Macclesfield Express - - WILDLIFE -

A SCI­EN­TIST from Prest­bury has been given a pres­ti­gious po­si­tion at an in­vest­ment com­pany.

Dr Clive Mor­ris, who is vice pres­i­dent and head of UK strate­gic sites at As­traZeneca, has been given the role of nonex­ec­u­tive di­rec­tor to help the firm un­der­stand the science be­hind the global food se­cu­rity mar­kets.

Dr Mor­ris, from Prest­bury, joined the group in June and brings a sci­en­tific per­spec­tive on the latest de­vel­op­ments in food se­cu­rity as well as spe­cial­ist knowl­edge of in­ter­na­tional busi­ness and re­search and de­vel­op­ment.

Graham Rams­bot­tom, chief ex­ec­u­tive of­fi­cer of Wheat­sheaf Group, said: “Clive will en­hance our un­der­stand­ing of sci­en­tific de­vel­op­ments in global food se­cu­rity mar­kets through his spe­cial­ist knowl­edge and his ex­pe­ri­ence of both in­ter­na­tional busi­ness in the phar­ma­ceu­ti­cal sec­tor and in­ter­na­tional re­search pro­grammes.”

In his cur­rent role, Mr Mor­ris has trans­formed the drug giants’ UK re­search and de­vel­op­ment sites in­clud­ing lead­ing the re­de­vel­op­ment of a ma­jor R&D site and the de­sign, plan­ning and con­struc­tion of a new fa­cil­ity and global HQ in Cam­bridge.

He said: “The is­sues be­ing tack­led by the Wheat­sheaf team and port­fo­lio com­pa­nies are of para­mount im­por­tance now and for fu­ture gen­er­a­tions, and I re­ally look for­ward to work­ing with them to make real progress in these ar­eas.”

Ex­pe­ri­enced across all phases of drug de­vel­op­ment, Mr Mor­ris has led teams re­spon­si­ble for many treat­ments and pi­o­neered As­traZeneca’s in­no­va­tive col­lab­o­ra­tive ap­proach to re­search which has de­liv­ered strate­gic part­ner­ships with groups such as Med­i­cal Re­search Coun­cil and the Amer­i­can Na­tional In­sti­tute of Health.

Newspapers in English

Newspapers from UK

© PressReader. All rights reserved.